| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A machine learning method integrating ECG and gated SPECT for cardiac resynchronization therapy decision support
|
de A. Fernandes, Fernando
|
|
|
50 |
10 |
p. 3022-3033
|
artikel
|
| 2 |
A pharmacological imaging challenge based on 11C-buprenorphine PET-MRI to explore the response to opioids in humans
|
Leroy, Claire
|
|
|
50 |
10 |
p. 3153-3154
|
artikel
|
| 3 |
A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer
|
Wang, Guochang
|
|
|
50 |
10 |
p. 3126-3136
|
artikel
|
| 4 |
Biodistribution and radiation dosimetry in cancer patients of the ascorbic acid analogue 6-Deoxy-6-[18F] fluoro-L-ascorbic acid PET imaging: first-in-human study
|
Long, Yali
|
|
|
50 |
10 |
p. 3072-3083
|
artikel
|
| 5 |
Bladder paraganglioma detection with [18F]MFBG PET/CT: a superior alternative to [68Ga]Ga-DOTATATE
|
Wang, Peipei
|
|
|
50 |
10 |
p. 3147-3148
|
artikel
|
| 6 |
Correction to: EANM enabling guide: how to improve the accessibility of clinical dosimetry
|
Gear, Jonathan
|
|
|
50 |
10 |
p. 3157-3158
|
artikel
|
| 7 |
Correction to: One‑stop [18F]FDG and [68Ga]Ga‑DOTA‑FAPI‑04 total‑body PET/CT examination with dual‑low activity: a feasibility study
|
Liu, Guobing
|
|
|
50 |
10 |
p. 3159
|
artikel
|
| 8 |
Defining the role of nuclear medicine in haematological tumours—EANM Focus 4: consensus on molecular imaging and therapy in haematological tumours
|
Nanni, Cristina
|
|
|
50 |
10 |
p. 2925-2926
|
artikel
|
| 9 |
Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer
|
Muehlematter, Urs J.
|
|
|
50 |
10 |
p. 3137-3146
|
artikel
|
| 10 |
Excretion of glucose analogue with SGLT2 affinity predicts response effectiveness to sodium glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus
|
Geist, Barbara Katharina
|
|
|
50 |
10 |
p. 3034-3041
|
artikel
|
| 11 |
FAP expression in alpha cells of Langherhans insulae—implications for FAPI radiopharmaceuticals’ use
|
Kirienko, Margarita
|
|
|
50 |
10 |
p. 3042-3049
|
artikel
|
| 12 |
Fibroblast activation protein (FAP)-targeted radionuclide therapy: which ligand is the best?
|
Chakravarty, Rubel
|
|
|
50 |
10 |
p. 2935-2939
|
artikel
|
| 13 |
[18F]MFBG PET/CT outperforming [123I]MIBG SPECT/CT in the evaluation of neuroblastoma
|
Wang, Peipei
|
|
|
50 |
10 |
p. 3097-3106
|
artikel
|
| 14 |
GCP III is not the “off-target” for urea-based PSMA ligands
|
Lee, Zhenghong
|
|
|
50 |
10 |
p. 2944-2946
|
artikel
|
| 15 |
Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides
|
Millul, Jacopo
|
|
|
50 |
10 |
p. 3050-3061
|
artikel
|
| 16 |
Intriguing information from recent letter and article regarding unwanted targeting of salivary glands by PSMA ligands
|
Huang, Steve S.
|
|
|
50 |
10 |
p. 2950-2951
|
artikel
|
| 17 |
In vivo evaluation of a novel 18F-labeled PET radioligand for translocator protein 18 kDa (TSPO) in monkey brain
|
Yan, Xuefeng
|
|
|
50 |
10 |
p. 2962-2970
|
artikel
|
| 18 |
Machine learning identifies multi-parametric functional PET/MR imaging cluster to predict radiation resistance in preclinical head and neck cancer models
|
Boeke, Simon
|
|
|
50 |
10 |
p. 3084-3096
|
artikel
|
| 19 |
Melanin-targeted [18F]-PFPN PET imaging for prognosticating patients with melanoma
|
Zhang, Xiao
|
|
|
50 |
10 |
p. 3062-3071
|
artikel
|
| 20 |
Metastatic melanoma extending along the inferior vena cava to its branches and venous plexus: a rare route metastasis characterized by [18F]FDG PET/CT
|
Zhou, Wenlan
|
|
|
50 |
10 |
p. 3149-3150
|
artikel
|
| 21 |
Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors
|
Kosmala, Aleksander
|
|
|
50 |
10 |
p. 3011-3021
|
artikel
|
| 22 |
Molecular imaging phenotyping of germline fumarate hydratase (FH) pathogenic variant-positive metastatic pheochromocytoma
|
Imperiale, Alessio
|
|
|
50 |
10 |
p. 3155-3156
|
artikel
|
| 23 |
PET imaging of tumor vascular normalization in hepatocellular carcinoma
|
An, Shuxian
|
|
|
50 |
10 |
p. 2940-2943
|
artikel
|
| 24 |
PET/MRI in practice: a clinical centre survey endorsed by the European Association of Nuclear Medicine (EANM) and the EANM Forschungs GmbH (EARL)
|
Prakken, Niek H. J.
|
|
|
50 |
10 |
p. 2927-2934
|
artikel
|
| 25 |
Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma
|
Zhu, Wenjia
|
|
|
50 |
10 |
p. 3116-3125
|
artikel
|
| 26 |
Preclinical evaluation of 68Ga-radiolabeled trimeric affibody for PDGFRβ-targeting PET imaging of hepatocellular carcinoma
|
Cai, Huawei
|
|
|
50 |
10 |
p. 2952-2961
|
artikel
|
| 27 |
Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken'
|
Boschi, Stefano
|
|
|
50 |
10 |
p. 2921-2924
|
artikel
|
| 28 |
Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma
|
Zhou, Xiang
|
|
|
50 |
10 |
p. 3107-3115
|
artikel
|
| 29 |
Response to: GCP III is not the “off-target” for urea-based PSMA-ligands
|
Bassi, Gabriele
|
|
|
50 |
10 |
p. 2947-2949
|
artikel
|
| 30 |
Sarcoidosis mimicking nodal manifestations of marginal zone lymphoma
|
Enke, Johanna S.
|
|
|
50 |
10 |
p. 3151-3152
|
artikel
|
| 31 |
The predictive value of pretherapy [68Ga]Ga-DOTA-TATE PET and biomarkers in [177Lu]Lu-PRRT tumor dosimetry
|
Akhavanallaf, Azadeh
|
|
|
50 |
10 |
p. 2984-2996
|
artikel
|
| 32 |
The relationship between tumour dosimetry, response, and overall survival in patients with unresectable Neuroendocrine Neoplasms (NEN) treated with 177Lu DOTATATE (LuTate)
|
Alipour, R.
|
|
|
50 |
10 |
p. 2997-3010
|
artikel
|
| 33 |
The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
|
Mauguen, Audrey
|
|
|
50 |
10 |
p. 2971-2983
|
artikel
|
Tijdschrift beschrijving